Canadian femtech companies are reshaping women’s healthcare by building platforms that put control and data management in the hands of users, drawing strong venture capital support as they address unmet needs in fertility, hormonal health, and workplace wellness.
- myStoria secured $1.65M seed funding to expand women’s health management tools.
- Femtech sector in Canada has grown from 51 to 200 companies recently.
- Investors link women’s health innovation to wider economic infrastructure benefits.
What happened
Canadian femtech startup myStoria recently raised $1.65 million in seed funding to enhance its platform that enables women to consolidate health documents, symptom tracking, and appointment histories. The startup uses AI to provide context and facilitate healthcare management focused on fertility, menstrual health, endometriosis, and perimenopause.
The funding round, led by Graphite Ventures with participation from Conexus Venture Capital, Adrenaline Fund, and Phoenix Fire Fund, reflects growing investor interest in femtech startups across Canada. This trend is supported by a surge in early-stage rounds for companies tackling various women's health challenges, despite historical underfunding in the sector.
Why it matters
Women’s health remains historically under-addressed by traditional healthcare systems and investment markets, often regarded as niche despite affecting half the population. Femtech is evolving beyond fertility and period tracking to incorporate workplace insurance, data infrastructure, and holistic healthcare solutions.
Industry leaders emphasize the economic importance of women’s health, linking it directly to workforce participation and broader economic infrastructure. Conditions such as menopause, menstrual-related stress, and postpartum depression significantly affect work performance and participation, making femtech innovation critical for societal and economic advancement.
What to watch next
With the femtech sector in Canada growing from 51 to 200 companies, startups that develop integrated virtual healthcare platforms addressing chronic and complex women’s health conditions are likely to attract further investment. Observers expect more specialized services like longevity and wellness concierge for hormonal health to emerge.
The intersection of women’s health, data management, and workplace benefits will continue to be a focal point, as venture funds like The51, backed by major financial institutions, prioritize solutions that advance women’s economic participation. Future growth will likely hinge on bridging healthcare gaps via technology that supports long-term outcomes and expanded access.